Literature DB >> 2920586

Phenotype of blood monocytes and alveolar macrophages in interstitial lung disease.

H C Hoogsteden1, J J van Dongen, P T van Hal, M Delahaye, W Hop, C Hilvering.   

Abstract

The immunologic phenotype of the monocyte-macrophage cell populations in bronchoalveolar lavage (BAL) fluid and monocytes in peripheral blood (PB) were studied in 20 patients with sarcoidosis, 18 with idiopathic pulmonary fibrosis (IPF), seven with extrinsic allergic alveolitis (EAA), and 12 healthy volunteers. There were no significant differences in expression of the immunologic markers CD13(My7), CD14(My4), and Monocyte-2 on blood monocytes between the patient groups and healthy volunteers, but there were marked differences between groups in the expression of the three markers on BAL macrophages. The percentage of Monocyte-2+ macrophages was increased in BAL in subjects with sarcoidosis, EAA, and IPF compared with healthy volunteers, greatest in EAA. This increase is probably due to increased recruitment of blood monocytes into alveoli, since the cells had a monocytic morphology on phase contrast microscopy (in normal subjects the majority of blood monocytes, but few alveolar macrophages, express the Monocyte-2 antigen). Patients with IPF had a significantly lower percentage of CD13(My7)+ macrophages in BAL than the other three groups. Compared with IPF patients and healthy volunteers, patients with EAA had a significantly higher percentage of CD14(My4)+ macrophages, whereas in sarcoidosis patients the numbers were reduced. These observations suggest an increased influx of blood monocytes into the alveoli in interstitial lung disorders. Phenotypic differences were found between the BAL macrophage populations of the various interstitial diseases. These differences in alveolar macrophage phenotype may be due to local factors, depending on the type of inflammation.

Entities:  

Mesh:

Year:  1989        PMID: 2920586     DOI: 10.1378/chest.95.3.574

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Phenotypic markers of alveolar macrophage maturation in pulmonary sarcoidosis.

Authors:  I Stríz; Y M Wang; H Teschler; C Sorg; U Costabel
Journal:  Lung       Date:  1993       Impact factor: 2.584

2.  Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults.

Authors:  W M Manimtim; J D Hasday; L Hester; K D Fairchild; J C Lovchik; R M Viscardi
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Expression of the CD11/CD18 cell surface adhesion glycoprotein family and MHC class II antigen on blood monocytes and alveolar macrophages in interstitial lung diseases.

Authors:  H C Hoogsteden; P T van Hal; J M Wijkhuijs; W Hop; C Hilvering
Journal:  Lung       Date:  1992       Impact factor: 2.584

4.  Evaluation of soluble CD 14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis.

Authors:  J Homolka; J Lorenz; H D Zuchold; J Müller-Quernheim
Journal:  Clin Investig       Date:  1992-10

5.  Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs.

Authors:  T R Martin; J C Mathison; P S Tobias; D J Letúrcq; A M Moriarty; R J Maunder; R J Ulevitch
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

6.  Enhancement of the antigen-presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanisms in extrinsic allergic alveolitis and atherosclerosis.

Authors:  D A Hughes; P J Townsend; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

7.  Alveolar macrophages from patients with bronchogenic carcinoma and sarcoidosis similarly express monocyte antigens.

Authors:  I L Barbosa; V A Gant; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

8.  Presence of mRNA for interferon-gamma (IFN-gamma) in blood mononuclear cells is associated with an active stage I sarcoidosis.

Authors:  C Swider; A Laba; A Moniewska; J Gerdes; H D Flad; A Lange
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

9.  Functional characterisation of human pulmonary monocyte-like cells in lipopolysaccharide-mediated acute lung inflammation.

Authors:  Mairi Brittan; Laura C Barr; Niall Anderson; Andrew Conway Morris; Rodger Duffin; John A Marwick; Fiona Rossi; Shonna Johnson; Kev Dhaliwal; Nikhil Hirani; Adriano G Rossi; A John Simpson
Journal:  J Inflamm (Lond)       Date:  2014-03-31       Impact factor: 4.981

10.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.